News We’re Watching – FDA Mammography Update, SVB Collapse, Zoll's Data Breach, And More
Executive Summary
News we are keeping an eye on this week includes the FDA’s first traditional market authorization for a COVID-19 test and its approval of a new neurological diagnostic. The agency also updated its device shortage list and revised mammography guidelines.
You may also be interested in...
SVB Failure Could Exacerbate Tight Credit, Drive Biopharma Consolidation
An economist told Scrip that banks could become more cautious about handing out loans to biotech start-ups, driving more M&A in the sector.
SVB UK’s Rescue Good News For Europe’s Fragile Biotech Sector
The British government helped secure HSBC as a buyer for SVB UK, but sector leaders want to see more support in the shape of sustained R&D tax relief.
EU MDR Notified Bodies Reach 38 After Another Designation
Germany’s SZUTEST is the latest notified body to be designated under the EU Medical Device Regulation, bringing the total number to 38.